Most Undervalued Healthcare stocks
Among the largest Healthcare companies ATLAS tracks, Novartis AG (NVS) sits furthest below ATLAS fair value (38% below fair value), followed by AstraZeneca and Gilead Sciences.
Updated Nov 6, 2026. Educational information, not investment advice.
The most undervalued Healthcare stocks among the largest Healthcare companies ATLAS tracks, ranked by how far they sit from ATLAS fair value. Figures match what ATLAS shows on each stock's page.
| # | Company | Vs ATLAS fair value | Price | Market cap |
|---|---|---|---|---|
| 1 | NVS Novartis AG | 38% below fair value | $162.55 | $292B |
| 2 | AZN AstraZeneca | 18% below fair value | $186.43 | $270B |
| 3 | GILD Gilead Sciences | 16% below fair value | $166.89 | $197B |
| 4 | AMGN Amgen | about fair value | $460.42 | $252B |
| 5 | UNH UnitedHealth Group | 24% above fair value | $394.15 | $355B |
| 6 | ABBV AbbVie | 38% above fair value | $291.31 | $514B |
| 7 | JNJ Johnson & Johnson | 42% above fair value | $276.22 | $599B |
| 8 | MRK Merck & Co. | 64% above fair value | $146.73 | $348B |
| 9 | LLY Eli Lilly | 67% above fair value | $1,354.00 | $1.1T |
| 10 | TMO Thermo Fisher Scientific | 74% above fair value | $694.76 | $254B |
Ranked across the largest Healthcare companies ATLAS tracks. Prices are in USD; market cap is in USD. A gap to fair value is a model estimate, not a price target.
Most Undervalued Healthcare stocks — common questions
What are the most undervalued Healthcare stocks per ATLAS?
Novartis AG (NVS), AstraZeneca and Gilead Sciences trade furthest below ATLAS fair value among the largest Healthcare companies. ATLAS compares each stock's price with its estimated fair value — the bigger the discount, the larger the gap below that estimate.
How does ATLAS decide which Healthcare stocks are undervalued?
ATLAS estimates a fair value for each company and measures how far the current price sits below it. This page ranks the largest Healthcare companies by that gap; it is a model estimate, not a price target.
Is this a list of Healthcare stocks to buy?
No. ATLAS is educational information, not investment advice. This ranking describes a single metric and is not a recommendation to buy or sell any stock.
Track Healthcare stocks on ATLAS — probability, fair value and earnings for NVS, AZN and 50,000+ more.
Open ATLAS free →ATLAS is educational information, not investment advice. Rankings describe a single metric and are not recommendations. Figures update roughly every few hours.